SPDR Dow Jones Industrial Average ETF

SPDR S&P 500 ETF Trust

Invesco QQQ Trust Series 1

Tesla, Inc. engages in the design, development, manufacture, and sale of electric vehicles and energy generation and storage systems. It operates through the Automotive and Energy Generation and Storage segments. The Automotive segment includes the design, development, manufacture, sale, and lease of electric vehicles as well as sales of automotive regulatory credits. The Energy Generation and Storage segment is involved in the design, manufacture, installation, sale, and lease of solar energy generation, energy storage products, and related services and sales of solar energy systems incentives. The company was founded by Jeffrey B. Straubel, Elon Reeve Musk, Martin Eberhard, and Marc Tarpenning on July 1, 2003 and is headquartered in Austin, TX.

Tesla Inc

Tesla is facing significant downward pressure as investors react to a combination of disappointing quarterly delivery figures, J.P. Morgans analyst downgrade citing major downside risk, and growing community speculation that capital is rotating out of the stock in anticipation of the upcoming SpaceX IPO. Amidst a volatile geopolitical climate, discussions on the platform are dominated by debates over leadership, the company's long-term competitive moat in the EV and AI space, and highly active trading around the stock's technical support levels.

Enovix Corp. engages in the design and development of silicon-anode lithium-ion batteries. The firm's proprietary 3D cell architecture increases energy density and maintains a high cycle life. It is also developing its 3D cell technology and production process for the electric vehicle and energy storage markets to help enable utilization of renewable energy. The company was founded by Mr. Harrold Jones Rust, III, Ashok Lahiri, and Murali Ramasubramanian in November 2006 and is headquartered in Fremont, CA.

Enovix Corporation

Enovix Corp

Enovix is currently trending as investors debate the company's ability to overcome manufacturing hurdles at its Malaysia facility, specifically relating to laser dicing and production yields. While the community remains polarized between those viewing the stock as a distressed 'zombie' play and long-term believers citing institutional ownership and potential partnerships, high short interest and anticipation of upcoming purchase orders keep sentiment highly volatile.

FuboTV, Inc. is a consumer-first live TV streaming company with the mission of delivering premium sports, news and entertainment programming that offers greater choice, flexibility and value. The company was founded by David Gandler, Alberto Horihuela Suarez, and Sung Ho Choi on February 20, 2009 and is headquartered in New York, NY.

fuboTV Inc - Ordinary Shares - Class A

fuboTV Inc

Fubo is facing intense debate as investors weigh the company's long-term financial guidance against a sharp price decline following a recent reverse stock split. The community remains deeply polarized, with some bulls pointing to sports-streaming dominance as a reason to hold, while skeptical traders focus on persistent bearish momentum and management's silence as catalysts for further short-selling.

Aehr Test Systems engages in the design, manufacture, market, and sale of test and burn-in equipment used in the semiconductor industry. Its products include FOX-XP, FOX-NP, and FOX-CP wafer contact parallel test and burn-in systems, the WaferPak full wafer contactor, the DiePak Carrier, the WaferPak Aligner, the DiePak Autoloader, and test fixtures. The company was founded by Rhea J. Posedel on May 25, 1977 and is headquartered in Fremont, CA.

Aehr Test Systems

Aehr Test Systems is surging as investors cheer the company's strategic pivot into AI infrastructure and recent high-profile production orders for its ultra-high-power testing systems. The community is heavily focused on the company's role as a critical bottleneck gatekeeper for reliability in the hyperscale data center supply chain, fueling bullish sentiment around upcoming earnings and guidance.

“Buttcoin - The Next Bitcoin” is the memecoin version of Bitcoin. Launched on January 30, 2025, on Pump.fun, it’s a community-owned memecoin on Solana. The idea was inspired by a 4:20 minutes long YouTube video from 2013 called "The Next Bitcoin?" by James D. McMurray.

Buttcoin

Buttcoin is gaining attention as a long-standing meme project, with the community actively debating whether its 15-year history of mocking the crypto industry translates into lasting value or a satirical phenomenon. Supporters are pushing the asset as a nostalgic, culture-driven alternative to mainstream tokens, while others view the surrounding social media fervor as a cautionary example of speculative retail behavior.

Direxion Shares ETF Trust - Direxion Daily TSLA Bull 2X ETF

Direxion Daily TSLA Bull 2X Shares

TSLL is drawing heavy trader interest as the community debates whether recent volatility and price action represent a durable support level or a setup for further downside. Investors are actively discussing the impact of leverage decay, institutional algorithmic manipulation, and conflicting sentiment regarding the long-term viability of high-growth technology promises.

iShares Bitcoin Trust ETF (The) - iShares Bitcoin Trust Beneficial Interest

iShares Bitcoin ETF

IBIT is trending as institutional investors and whales navigate heightened volatility, with intense community debate over recent ETF accumulation patterns, broader macro pressures, and the potential impact of ongoing market manipulation allegations. The stock remains a focal point for both bulls eyeing long-term adoption and bears focused on short-term price weakness and systemic risks.

Himax Technologies, Inc. is a semiconductor solution provider dedicated to display imaging processing technologies. It operates through the Driver Integrated Circuit and Non-Driver Products segments. The company's products include display drivers, timing controllers, wafer level optics, video and display technology solutions, liquid crystal over silicon silicon, complementary metal-oxide semiconductor image sensor, and power integrated circuit. Its products used in TVs, laptops, monitors, mobile phones, tablets, digital cameras, car navigation, virtual reality (VR) devices and many other consumer electronics devices. Himax Technologies was founded by Biing Seng Wu and Jordan Wu on June 12, 2001 and is headquartered in Tainan, Taiwan.

Himax Technologies - ADR

Himax Technologies, Inc.

Himax Technologies is trending as investors actively debate its long-term potential as a supplier for the Co-Packaged Optics (CPO) market, with community discussions focused on its strategic integration into next-generation AI data center roadmaps. While shareholders remain divided over the company's historical management performance, recent news cycles highlighting its role in emerging optical component supply chains have reignited interest in its growth prospects.

Enphase Energy, Inc. is a global energy technology company, which engages in the business of designing, developing, manufacturing, and selling home energy solutions that manage energy generation, energy storage, control, and communications on one intelligent platform. It operates through the following geographical segments: the United States, the Netherlands, and Others. The company was founded by Raghuveer R. Belur and Martin Fornage in March 2006 and is headquartered in Fremont, CA.

Enphase Energy Inc

Enphase Energy is experiencing significant volatility as investors weigh a strong quarterly earnings beat and positive guidance against broader solar sector headwinds and concerns over upcoming debt obligations. The community remains deeply polarized, with some bulls highlighting the long-term potential of residential solar and battery storage in an AI-driven energy economy, while others express frustration over the stock's persistent downtrend, regulatory uncertainty, and aggressive short-selling activity.

Soleno Therapeutics, Inc. operates as clinical-stage biopharmaceutical company, which engages in the development and commercialization of novel therapeutics for the treatment of rare diseases. It focuses on the treatment of metabolic and neurobehavioral disorder. It offers its lead candidate, Diazoxide Choline Controlled-Release (DCCR), an oral tablet for the treatment of Prader-Willi Syndrome (PWS). The company was founded on August 25, 1999 and is headquartered in Redwood City, CA.

Soleno Therapeutics Inc

statis crypto Watchlist

Bitcoin

Ethereum

Solana

Ripple

Dogecoin

Cardano

statis IN Watchlist

Nifty 50

Nifty Bank

Reliance Industries Ltd.

Zomato Ltd.

Tata Consultancy Services

Tata Motors Ltd.

HDFC Bank Ltd.

ITC Ltd.

Adani Enterprises Ltd

Axis Bank Ltd

Bajaj Finance Ltd

statis US Watchlist

SPDR S&P 500 ETF

Apple Inc.

Microsoft Corporation

NVIDIA Corp

 Hey, I want to invite you to join Stocktwits. It’s the largest global community of active traders. You’ll get access to the real-time market insights, news, discussion and much more! You can sign up using my unique link below 
 


 has invited you to join Stocktwits

<ul class="summary-bullets"><li>Repositioning charge consists of $111 million charge reflected in compensation and employee benefits.</li><li>State Street reported adjusted earnings per share of $2.97 for the quarter, surpassing analyst estimates of $2.78 per share.</li><li>The company’s total expenses in the quarter increased by 6%, excluding notable items.&nbsp;</li></ul><p>Shares of custodian bank State Street (STT) dived on Friday after it disclosed that it took a repositioning charge during the fourth quarter that weighed on its profit.</p><p>The bank said repositioning charges (net) of $226 million in the quarter represents a $111 million charge reflected in compensation and employee benefits primarily from workforce rationalization and a $69 million charge reflected in occupancy costs associated with real estate footprint optimization.</p><p>The company also saw its total expenses in the quarter increase by 12%, primarily driven by investments in its business and technology capabilities and revenue-related costs.&nbsp;</p><p>Strong Q4 Results</p><p>State Street reported adjusted earnings per share of $2.97 for the quarter, surpassing analyst estimates of $2.78 per share. Its revenue totaled $3.67 billion, beating consensus estimate of $3.57 billion and representing a 7% increase year-over-year, as per data from fiscal.ai.</p><p>"2025 marked another year of strong performance and strategic progress for State Street. We delivered robust financial results, achieving positive operating leverage, expanding pre-tax margin, and generating higher returns,” said Ron O’Hanley, Chairman and CEO at State Street.</p><h2 class="st-heading-2">Push Into Digital Assets</h2><p>State Street earlier in the week announced the launch of its Digital Asset Platform, an infrastructure for tokenized assets. The platform strategically positions State Street to be the bridge between traditional and digital finance and the connection point between digital asset platforms for its clients.</p><p>The launch enables State Street's digital ambitions to develop core products for its clients, including tokenized Money Market Funds, ETFs, tokenized assets, and cash products including tokenized deposits and stablecoins.&nbsp;</p><p>The platform includes wallet management, custodial, and cash capabilities, designed to support tokenized product development across jurisdictions covering both private and public permissioned blockchain networks, it said.&nbsp;</p><h2 class="st-heading-2">Other Firms Into Digital Push</h2><p>Earlier this week, BNY, a global financial services company, took its first step in its strategy to tokenize deposits by enabling the on‑chain mirrored representation of client deposit balances on its Digital Assets platform.&nbsp;</p><p>Global financial markets are shifting towards an always-on operating model, due to which institutions are seeking faster and more efficient ways to move assets with greater settlement certainty, transparency. Tokenized deposits can help to reduce settlement friction, improve liquidity efficiency across collateral and margin workflows, and enable programmable payments and settlements.</p><h2 class="st-heading-2">How Did Stocktwits Users React?</h2><p>Retail sentiment around STT trended in ‘extremely bullish’ territory amid ‘high’ message volume.</p><p>Shares of State Street have risen 31% over the past 12 months.&nbsp;<br>&nbsp;</p>

In this photo illustration, State Street Corporation logo is seen on a smartphone screen. 

Why Are State Street Shares Falling Today?

The bank booked repositioning charges of $226 million in the quarter primarily from workforce rationalization occupancy costs associated with real estate footprint optimization.

Equity

The bank booked repositioning charges of $226 million in the quarter primarily from workforce rationalization occupancy costs associated with real estate footprint optimization.


<ul class="summary-bullets"><li>UBS reiterated its Neutral stance on Nike, citing strong brand equity but a prolonged recovery timeline.</li><li>It believes Nike’s brand strength should support a long-term recovery.</li></ul><p>Shares of Nike (<a href="https://stocktwits.com/symbol/NKE">NKE</a>) were in the spotlight on Friday after UBS analyst Jay Sole said Nike’s brand remains strong, which will help the sportswear firm turn around its ongoing struggles; however, the turnaround will take longer than the market expects.</p><p>As per TheFly, UBS said in a note that it continues to believe Nike's business will improve. It rated the stock as “Neutral,” saying that the rating reflects the view that the company's turnaround will take longer than the market expects. UBS maintained a $62 price target on Nike shares.</p><h2 class="st-heading-2">Turbulent Few Years</h2><p>Nike has seen leadership changes, management resets, excess inventory, and renewed focus on innovation, leading to a slow, uneven turnaround under scrutiny.</p><p>Nike has worked to clean up excess inventory, particularly by reducing production of legacy franchises such as Air Jordans and Air Force 1s. While the reset pressured near-term results, the company said in December that inventory levels are now healthy across North America, EMEA, and other key regions.</p><h2 class="st-heading-2">Struggles In China</h2><p>The struggle in China has been longstanding for Nike, as it is continuing to face steep competition from other retailers. The recent tariff war between the two largest economies has further slowed Nike’s efforts to gain market share in China’s booming outdoor sports market.</p><p>Nike, in its recently reported second-quarter results, said its footwear sales in China fell 21%, and overall sales fell 17% to $1.42 billion. The China region accounts for nearly 15% of Nike’s annual revenue.</p><h2 class="st-heading-2">Tim Cook’s Vote Of Confidence</h2><p>Apple CEO Tim Cook has, time and again, through strategic shifts, market scepticism, and operational missteps, publicly and privately reinforced his confidence in Nike, lending credibility when the brand needed it most.</p><p>Cook has been on Nike’s board since 2005. He recently echoed his long-standing relationship with Nike after it made an open-market purchase of about $3 million worth of the company’s stock, a personal investment.&nbsp;</p><h2 class="st-heading-2">How Did Stocktwits Users React?</h2><p>Retail sentiment on NKE trended in ‘extremely bullish’ amid ‘high’ message levels.</p><figure class="image"><img style="aspect-ratio:638/65;" src="https://news.stocktwits-cdn.com/NKE_Sentiment_PNG_da214e3bac.webp" alt="Retail sentiment on NKE trended in ‘extremely bullish’ amid ‘high’ message levels." width="638" height="65"></figure><p><br><i>For updates and corrections, email newsroom[at]stocktwits[dot]com.</i><br>&nbsp;</p>

A garden in the shape of a Nike corporate logo is seen in an office building patio in midtown Manhattan on April 6, 2023, in New York City. (Photo by Gary Hershorn/Getty Images)

Nike Turnaround Faces A Longer Road Despite Brand Strength, UBS Says 

It maintained a $62 price target as inventory, China weakness, and competition weigh on momentum.

<ul class="summary-bullets"><li>UNH raised its full-year adjusted earnings guidance to at least $16.25 per share, up from its previous outlook of at least $16.&nbsp;</li><li>However, company executives warned on the company’s earnings call that the path to recovery in its Medicaid business will be challenging.</li><li>They noted that medical cost trends remain historically high but consistent with the company’s second-quarter guidance.&nbsp;</li></ul><p>UnitedHealth Group (UNH) on Tuesday raised its full-year adjusted earnings guidance to at least $16.25 per share, up from its previous outlook of at least $16, as it seeks to return to growth in 2026.</p><p>“We remain focused on strengthening performance and positioning for durable and accelerating growth in 2026 and beyond, and our results this quarter reflect solid execution toward that goal,” said CEO Stephen Hemsley.</p><p>“Simply put, we will end 2025 well-positioned for a return to solid growth in 2026, acceleration in 2027, and a clear focus on our long-standing mission and strategy,” the CEO noted during the company’s third quarter (Q3) earnings call, while adding that the company intends to share its 2026 full guidance in January with its fourth quarter (Q4) earnings.</p><p>Hemsley took over the reins of the company in May after former CEO Andrew Witty stepped down. He is also the chairman of UNH’s board of directors.</p><h2 class="st-heading-2">Execs Flag Concerns On Medicaid Business Recovery</h2><p>However, company executives warned on the earnings call that the path to recovery for the company’s Medicaid business will be challenging. Medicaid is a joint federal and state program in the United States that provides low-cost or free health coverage to eligible low-income individuals.</p><p>“States have not funded in line with actual cost trends, so funding levels are not sufficient to cover the health needs of state enrollees. While we're making steady progress in bridging this gap with states, the mismatch between rate adequacy and member acuity will likely extend through 2026," Hemsley said, according to an earnings call transcript provided by Fiscal AI. A company executive also noted that the elevated cost trends in the business were driven by specialty pharmacy, behavioral health, and home health services in the third quarter.</p><h2 class="st-heading-2">UnitedHealth’s Q3 Numbers</h2><p>For the third quarter, the company <a class="st-link-external" target="_blank" rel="noopener noreferrer nofollow" href="https://www.unitedhealthgroup.com/newsroom/2025/2025-10-28-uhg-reports-third-quarter-2025-results-and-raises-full-year-2025-earnings-outlook.html">reported</a> a 12% increase in consolidated revenue to $113.2 billion, above an analyst estimate of $113.06 billion, as cited by Fiscal AI.</p><p>Adjusted earnings per share came in at $2.92, above an expected $2.81.</p><p>Medical cost ratio, or the percentage of premiums used on medical care, was 89.9%, in line with the expectations put forth by the company in the second quarter (Q2). Company executives noted on the earnings call that medical cost trends remain historically high but consistent with its second quarter guidance, and the insurer expects that to continue throughout the remainder of 2025.</p><p>The company’s revenue from its key Optum business segment, meanwhile, grew 8% year-over-year to $69.2 billion.</p><p>Shares of the company traded 2% higher at the time of writing. On Stocktwits, retail sentiment around <a href="https://stocktwits.com/symbol/UNH">UNH stock</a> jumped from ‘bearish’ to ‘extremely bullish’ territory over the past 24 hours, while message volume rose from ‘normal’ to ‘extremely high’ levels.</p><p>A Stocktwits user expressed optimism for the stock yielding significant profits in the future.</p><p><stembedurl>https://stocktwits.com/_Texan_/message/634014037</stembedurl></p><p>Another user resonated the sentiment.</p><p><stembedurl>https://stocktwits.com/Smoothbrainape/message/634012667</stembedurl></p><p>UNH stock is down by 27% this year and by about 34% over the past 12 months.&nbsp;</p><p>Read also: <a href="https://stocktwits.com/news-articles/markets/equity/tesla-on-look-out-for-manufacturing-engineer-to-advance-new-roadster-sports-ev/cLGjVUAR3vE">Tesla On The Look-Out For Manufacturing Engineer To Advance Its New Roadster Sports EV</a></p><p><i>For updates and corrections, email newsroom[at]stocktwits[dot]com.</i></p>

In this photo illustration, the UnitedHealth Group logo is displayed on the screen of a smartphone. (Photo Illustration by Sheldon Cooper/SOPA Images/LightRocket via Getty Images)

UnitedHealth Increases Full Year Earnings Forecast But Warns Of Tough Road Ahead For Medicaid Business

UNH raised its full-year adjusted earnings guidance to at least $16.25 per share, up from its previous outlook of at least $16. 

Current Price	$36.12
Prev Close	$36.14
Open	$36.12
Dividend Yield	N/A
50-Day Moving Average	$37.23
Beta	N/A
Avg. Volume	4,294.59
PE Ratio	N/A

52-Week High	$39.08
52-Week Low	$27.61
Market Capitalization	N/A
EPS (Annual)	N/A
Price to Book	N/A
Revenue Per Employee	N/A

KNGZ
First Trust Exchange-Traded Fund III - First Trust US Equity Dividend Select ETF

Feed

News

Sentiment

Fundamentals

Info

Latest KNGZ News

KNGZFirst Trust Exchange-Traded Fund III - First Trust US Equity Dividend Select ETF